Pulmonx LUNG
Pulmonx FY 2020: revenue $32.7M; diluted EPS −$3.16
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001127537-21-000008
Key figures from this report
These are the numbers Pulmonx reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$32.7MNo year-earlier figure tagged10-K income statement, on EDGAR
- Net income−$32.2MNo year-earlier figure tagged10-K income statement, on EDGAR
- Diluted EPS−$3.16No year-earlier figure tagged10-K income statement, on EDGAR
- Cash and cash equivalents$231.6MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
- Cash from operations−$30.6MNo year-earlier figure tagged10-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Microbot Medical MBOT public float $96M, Jun 30, 2025
- TriSalus Life Sciences TLSI public float $112M, Jun 30, 2025
- Fonar FONR
- CVRx CVRX public float $112M, Jun 30, 2025
- LENSAR LNSR public float $113M, Jun 30, 2025
